Astrocyte Pharmaceuticals

Small molecules for brain injury, concussions, stroke, and neurodegenerative disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2014 groups9 employees language astrocytepharma.com

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 1,373 times.

YearFilings
20171
20181
20192
20203
20213
20223
20234
20247
20256

Investor mix

16 investors on record; lead investors include Boston Harbor Angels, Dreavent.

Investor typeCountShare
Venture capital638%
Private equity16%
Angel & family office531%
Other / undisclosed425%
Coming soon